A Mayo Clinic study finds the risk is almost doubled for adults under 50, a group currently not broadly advised to get an RSV vaccine.
The reduction in transfers to emergency departments is driven by increased testing and case detection and faster flu antiviral initiation rather than smaller outbreaks.
A study of women in 8 countries finds that they often agree to RSV vaccination during pregnancy and believe it’s better than immunizing their babies directly.
A new study finds that benefits of mRNA technology are substantial and serious adverse events rare.
For well over a year, public health experts have been planning how to protect fans from infectious diseases such as flu, COVID, and measles (part 1 of 2).
The guidance illustrates the growing chasm between the medical organization and the federal health agency.
Study finds that when moms get vaccinated for respiratory syncytial virus while pregnant, RSV hospitalizations for babies decrease by 70%.
The RSV vaccine is different. It does not have a reputation problem or a trust problem. It has an awareness problem.
But timing matters: When administered at least 8 weeks before delivery, maternal vaccination appears equally effective.
One of the 6 studies shows that, given alone or together, maternal RSV vaccination and infant immunization with nirsevimab are safe and trigger a good immune response.
